NOT-AT-22-024: Notice of NCCIH's Withdrawal from Participation in PAR-22-075, " NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)

Notice of NCCIH's Withdrawal from Participation in PAR-22-075, " NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)

Notice Number:

NOT-AT-22-024

Key Dates

Release Date:

May 20, 2022

Related Announcements

PAR-22-075- NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)

Issued by

National Center for Complementary and Integrative Health (NCCIH)

Purpose

This Notice informs applicants that, effective September 8, 2022, NCCIH will no longer be participating in in PAR-22-075, " NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) , and will not accept applications to PAR-22-075.

The following changes have been made to PAR-22-075.

Current Text

Part 1. Overview Information

Components of Participating Organizations

National Institute of Allergy and Infectious Diseases (NIAID)

National Center for Complementary and Integrative Health (NCCIH)

Catalog of Federal Domestic

Assistance (CFDA) Number(s)

93.855, 93.213

Part 2. Full Text of Announcement, Section VII. Agency Contacts

Scientific/Research Contact(s)

Melissa Trevi o, PhD
National Center for Complementary & Integrative Health (NCCIH)
Telephone: 301-768-7115
Email: [email protected]

Email: [email protected]

Peer Review Contact(s)

Robert Unfer, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-641-1981
Email: [email protected]

Financial/Grants Management Contact(s)

Debbie Chen
National Center for Complementary and Integrative Health (NCCIH)
Telephone: 301-594-3788
Email: [email protected]

Samuel Ashe
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-435-4799
Email: [email protected]

Modified text:

Part 1. Overview Information

Components of Participating Organizations

National Institute of Allergy and Infectious Diseases (NIAID)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.855